Skip to main content

Advertisement

SpringerLink
Log in

Maintaining Fertility in Young Women with Breast Cancer

  • Breast Cancer
  • Published:
Current Treatment Options in Oncology Aims and scope Submit manuscript

Opinion statement

Breast cancer effects nearly 200,000 American women each year, with 9% of these women still in their childbearing years. For this subset of future survivors, the issue of fertility may be a significant quality-of-life concern. Both the causes and treatments for infertility in young breast cancer patients must be thoroughly understood by the multidisciplinary team caring for these women in order for the caregivers to be effective advocates for their patients. Radiation, cytotoxic chemotherapy, and hormonal therapy all effect ovarian function to greater or lesser degrees, with the incidence of permanent post-treatment amenorrhea following systemic treatment for breast cancer in women age 50 or younger estimated as between 33% and 76%. The science of fertility preservation continues to experience significant advances in terms of the success of oocyte, embryo, and ovarian tissue preservation, and it is crucial that physicians and patients are aware of the available fertility preservation options. The optimal time to address the possibility of treatment-related infertility and strategies to combat this with younger patients is prior to treatment, rather than after cancer therapy has begun, and a full knowledge of the available technologies is a prerequisite for an informed discussion. Causes of ovarian suppression and options for treatment, including consideration of preimplantation genetic diagnosis and alternative parenting approaches are also discussed to assist the clinician caring for young patients with cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

Papers of particular interest, published recently, has been highlighted as: • Of importance •• Of major importance

  1. Bines J, Oleske DM, Cobleigh MA: Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 1996,14(5):1718–1729.

    CAS  PubMed  Google Scholar 

  2. Tham YL, Sexton K, Weiss H, Elledge R, Friedman LC, Kramer R: The rates of chemotherapy-induced amenorrhea in patients treated with adjuvant doxorubicin and cyclophosphamide followed by a taxane. Am J Clin Oncol 2007, 30(2):126–132. doi:10.1097/01.coc.0000251398.57630.4f.

    Article  CAS  PubMed  Google Scholar 

This work describes the multidisciplinary approach to fertility preservation for patients with cancer.

  1. Woodruff TK: The emergence of a new interdiscipline: oncofertility. Cancer Treat Res 2007, 138:3–11. doi:10.1007/978-0-387-72293-1_1.

    Article  PubMed  Google Scholar 

This review introduced the concept of oncofertility and defines it as a new, emerging field.

  1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ: Cancer statistics, 2007. CA Cancer J Clin 2007, 57(1):43–66.

    Article  PubMed  Google Scholar 

  2. ACS. Breast Cancer Facts & Figures 2007–2008. Report. Atlanta, GA: American Cancer Society, Inc.; 2008

  3. Lee SJ, Schover LR, Partridge AH, et al.: American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 2006, 24(18):2917–2931.

    Article  PubMed  Google Scholar 

  4. Partridge AH, Gelber S, Peppercorn J, et al.: Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol 2004, 22(20):4174–4183.

    Article  PubMed  Google Scholar 

  5. Falcone T, Attaran M, Bedaiwy MA, Goldberg JM: Ovarian function preservation in the cancer patient. Fertil Steril 2004, 81(2):243–257.

    Article  PubMed  Google Scholar 

  6. Meirow D, Nugent D: The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update 2001, 7(6):535–543.

    Article  CAS  PubMed  Google Scholar 

  7. Maltaris T, Seufert R, Fischl F, et al.: The effect of cancer treatment on female fertility and strategies for preserving fertility. Eur J Obstet Gynecol Reprod Biol 2007, 130(2):148–155.

    Article  PubMed  Google Scholar 

  8. Wallace WH, Thomson AB, Saran F, Kelsey TW: Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys 2005, 62(3):738–744.

    PubMed  Google Scholar 

  9. Critchley HO, Wallace WH, et al.: Impact of cancer treatment on uterine function. J Natl Cancer Inst Monogr 2005, 34:64–68.

    Article  PubMed  Google Scholar 

  10. Fenig E, Mishaeli M, Kalish Y, Lishner M: Pregnancy and radiation. Cancer Treat Rev 2001, 27(1):1–7.

    Article  CAS  PubMed  Google Scholar 

  11. Mazonakis M, Varveris H, Damilakis J, Theoharopoulos N, Gourtsoyiannis N: Radiation dose to conceptus resulting from tangential breast irradiation. Int J Radiat Oncol Biol Phys 2003, 55(2):386–391.

    PubMed  Google Scholar 

  12. Antypas C, Sandilos P, Kouvaris J, et al.: Fetal dose evaluation during breast cancer radiotherapy. Int J Radiat Oncol Biol Phys 1998, 40(4):995–999.

    Article  CAS  PubMed  Google Scholar 

  13. Lutchman Singh K, Muttukrishna S, Stein RC, et al.: Predictors of ovarian reserve in young women with breast cancer. Br J Cancer 2007, 96(12):1808–1816.

    Article  CAS  PubMed  Google Scholar 

  14. Visser JA, Themmen AP: Anti-Mullerian hormone and folliculogenesis. Mol Cell Endocrinol 2005, 234(1–2):81–86.

    Article  CAS  PubMed  Google Scholar 

  15. Anders C, Marcom PK, Peterson B, et al.: A pilot study of predictive markers of chemotherapy-related amenorrhea among premenopausal women with early stage breast cancer. Cancer Invest 2008, 26(3):286–295.

    Article  CAS  PubMed  Google Scholar 

  16. Sonmezer M, Oktay K: Fertility preservation in female patients. Hum Reprod Update 2004, 10(3):251–266.

    Article  PubMed  Google Scholar 

  17. Petrek JA, Naughton MJ, Case LD, et al.: Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study. J Clin Oncol 2006, 24(7):1045–1051.

    Article  PubMed  Google Scholar 

  18. Maltaris T, Weigel M, Mueller A, et al.: Cancer and fertility preservation: fertility preservation in breast cancer patients. Breast Cancer Res 2008, 10(2):206.

    Article  PubMed  CAS  Google Scholar 

This is an excellent review of amenorrhea rates related to a variety of different chemotherapeutic regimens given to breast cancer patients, along with a review of fertility preservation strategies.

  1. Halakivi-Clarke L, Cho E, Onojafe I, Liao DJ, Clarke R: Maternal exposure to tamoxifen during pregnancy increases carcinogen-induced mammary tumorigenesis among female rat offspring. Clin Cancer Res 2000, 6(1):305–308.

    CAS  PubMed  Google Scholar 

  2. Barthelmes L, Gateley CA: Tamoxifen and pregnancy. Breast 2004, 13(6):446–451.

    Article  CAS  PubMed  Google Scholar 

  3. Gradishar WJ, Hellmund R: A rationale for the reinitiation of adjuvant tamoxifen therapy in women receiving fewer than 5 years of therapy. Clin Breast Cancer 2002, 2(4):282–286.

    Article  CAS  PubMed  Google Scholar 

  4. Arnon J, Meirow D, Lewis-Roness H, Ornoy A: Genetic and teratogenic effects of cancer treatments on gametes and embryos. Hum Reprod Update 2001,7(4):394–403.

    Article  CAS  PubMed  Google Scholar 

  5. Partridge AH, Ruddy KJ: Fertility and adjuvant treatment in young women with breast cancer. The Breast 2007, 16(Suppl 2):175–181.

    Article  Google Scholar 

  6. Lobo RA: Potential options for preservation of fertility in women. N Engl J Med 2005, 353(1):64–73.

    Article  CAS  PubMed  Google Scholar 

A comprehensive review which encompasses the scope of the problem of therapy induced amenorrhea and treatments. A later edition of the New England Journal (Volume 353(13):1418-1420) contained a commentary on this article by Dr. Pamela J Goodwin, in which she makes the important point that age is of utmost importance when estimating amenorrhea rates. Less than 5 percent of women under 30 years of age, almost 40 percent of 40-year-old women, and 80 percent of 45-year-old women enter menopause during the first year after starting chemotherapy.

  1. Recchia F, Saggio G, Amiconi G, et al.: Gonadotropin-releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma. Cancer 2006, 106(3):514–523.

    Article  CAS  PubMed  Google Scholar 

  2. Ambrosone GB, Barlow W, Yeh I-T, et al.: Pharmacogenetics and breast cancer treatment outcomes: results on oxidative stress-related genotypes (MPO, MnSOD) from a southwest oncology intergroup trial (INT-0102). Cancer 2006, 100:S18.

    Google Scholar 

  3. Urruticoechea A, Arnedos M, Walsh G, Dowsett M, Smith IE: Ovarian protection with goserelin during adjuvant chemotherapy for pre-menopausal women with early breast cancer (EBC). Breast Cancer Res Treat 2008, 110(3):411–416.

    Article  CAS  PubMed  Google Scholar 

  4. Cahill DJ, Wardle PG, Harlow CR, Hunt LP, Hull MG: Expected contribution to serum oestradiol from individual ovarian follicles in unstimulated cycles. Hum Reprod 2000, 15(9):1909–1912.

    Article  CAS  PubMed  Google Scholar 

  5. Gupta PB, Kuperwasser C: Contributions of estrogen to ER-negative breast tumor growth. J Steroid Biochem Mol Biol 2006, 102(1–5):71–78.

    Article  CAS  PubMed  Google Scholar 

  6. Oktay K, Buyuk E, Davis O, Yermakova I, Veeck L, Rosenwaks Z: Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen. Hum Reprod 2003, 18(1):90–95.

    Article  CAS  PubMed  Google Scholar 

  7. Oktay K: Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility preservation. J Clin Oncol 2005, 23(16):3858–3859.

    Article  PubMed  Google Scholar 

  8. Azim AA, Costantini-Ferrando M, Oktay K: Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J Clin Oncol 2008, 26(16):2630–2635.

    Article  CAS  PubMed  Google Scholar 

  9. Madrigrano A, Westphal L, Wapnir I: Egg retrieval with cryopreservation does not delay breast cancer treatment. Am J Surg 2007, 194(4):477–481.

    Article  PubMed  Google Scholar 

  10. Stachecki JJ, Cohen J: An overview of oocyte cryopreservation. Reprod Biomed Online 2004, 9(2):152–163.

    Article  PubMed  Google Scholar 

  11. Tao T, Del Valle A: Human oocyte and ovarian tissue cryopreservation and its application. J Assist Reprod Genet 2008, 25(7):287–296.

    Article  PubMed  Google Scholar 

  12. Porcu E, Bazzocchi A, Notarangelo L, Paradisi R, Landolfo C, Venturoli S: Human oocyte cryopreservation in infertility and oncology. Curr Opin Endocrinol Diabetes Obes 2008, 15(6):529–535.

    PubMed  Google Scholar 

  13. Backhus LE, Kondapalli LA, Chang RJ, Coutifaris C, Kazer R, Woodruff TK: Oncofertility consortium consensus statement: guidelines for ovarian tissue cryopreservation. Cancer Treat Res 2007, 138:235–239.

    Article  PubMed  Google Scholar 

  14. Sanchez M, Novella-Maestre E, Teruel J, Ortiz E, Pellicer A: The Valencia programme for fertility preservation. Clin Transl Oncol 2008, 10(7):433–438.

    Article  CAS  PubMed  Google Scholar 

  15. Demeestere I, Simon P, Emiliani S, Delbaere A, Englert Y: Fertility preservation: successful transplantation of cryopreserved ovarian tissue in a young patient previously treated for Hodgkin’s disease. Oncologist 2007, 12(12):1437–1442.

    Article  PubMed  Google Scholar 

  16. Donnez J, Dolmans MM, Demylle D, et al.: Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 2004, 364(9443):1405–1410.

    Article  CAS  PubMed  Google Scholar 

  17. Meirow D, Levron J, Eldar-Geva T, et al.: Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med 2005, 353(3):318–321.

    Article  CAS  PubMed  Google Scholar 

  18. Woodruff TK, Shea LD: The role of the extracellular matrix in ovarian follicle development. Reprod Sci 2007, 14(8 Suppl):6–10.

    Article  PubMed  Google Scholar 

  19. Xu M, Woodruff TK, Shea LD: Bioengineering and the ovarian follicle. Cancer Treat Res 2007, 138:75–82.

    Article  PubMed  Google Scholar 

While ovarian stimulation, harvest, and cryopreservation of oocytes and embryos which will be used for later in vitro fertilization remains the most prevalent approach to germ line preservation in cancer patients, this piece lays out the theory and work to date on the new technique of ovarian tissue harvest and in follicle maturation (IFM). The process of harvesting and growing oocytes in engineered hydrogel matrix highlights the necessity of a multidisciplinary approach to solving this problem, bringing together clinicians, engineers, biologists, and others.

  1. Telfer EE, McLaughlin M, Ding C, Thong KJ: A two-step serum-free culture system supports development of human oocytes from primordial follicles in the presence of activin. Hum Reprod 2008, 23(5):1151–1158.

    Article  CAS  PubMed  Google Scholar 

This work was the first to describe the use of a tissue engineered scaffold to allow for oocyte preservation, which ultimately resulted in the birth of healthy, fertile offspring using a mouse model.

  1. Xu M, Kreeger PK, Shea LD, Woodruff TK: Tissue-engineered follicles produce live, fertile offspring. Tissue Eng 2006, 12(10):2739–2746.

    Article  CAS  PubMed  Google Scholar 

  2. Verlinsky Y, Cohen J, Munne S, et al.: Over a decade of experience with preimplantation genetic diagnosis: a multicenter report. Fertil Steril 2004, 82(2):292–294.

    Article  PubMed  Google Scholar 

  3. Offit K, Kohut K, Clagett B, et al.: Cancer genetic testing and assisted reproduction. J Clin Oncol 2006, 24(29):4775–4782.

    Article  PubMed  Google Scholar 

  4. Staton AD, Kurian AW, Cobb K, Mills MA, Ford JM: Cancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers. Fam Cancer 2008, 7(2):179–186.

    Article  PubMed  Google Scholar 

  5. Menon SJ: Psychotropic medication during pregnancy and lactation. Arch Gynecol Obstet 2008, 277(1):1–13.

    Article  CAS  PubMed  Google Scholar 

  6. Rosen A: Third-party reproduction and adoption in cancer patients. J Natl Cancer Inst Monogr 2005, 34:91–93.

    Article  PubMed  Google Scholar 

The issues of discrimination and other obstacles surrounding adoption and third party reproduction for cancer patients has received little attention in the medical literature. This concise and elegant critique by Dr. Allison Rosen is an excellent starting point for clinicians to gain some knowledge and sensitivity to these important issues.

  1. Young women united against breast cancer: action, advocacy, awareness. young survival coalition, 2008 (accessed November 14, 2008, at http://www.youngsurvival.org)

  2. MyOncofertility.org. The Oncofertility Consortium, 2008 (accessed November 14, 2008, at http://www.myoncofertility.org)

  3. Fertile Hope. Fertile Hope, 2008 (accessed November 14, 2008, at http://www.fertilehope.org)

  4. Leslie M: Melting opposition to frozen eggs. Science 2007, 316(5823):388–389.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Northwestern University Feinberg School of Medicine, 303 East Superior Street, Lurie, 4-115, Chicago, IL, 60611, USA

    Melissa C. Hulvat MD & Jacqueline S. Jeruss MD, PhD

  2. Lynn Sage Comprehensive Breast Center, 250 E. Superior St., Prentice 4-420, Chicago, IL, 60611, USA

    Melissa C. Hulvat MD & Jacqueline S. Jeruss MD, PhD

  3. Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, 60611, USA

    Jacqueline S. Jeruss MD, PhD

Authors
  1. Melissa C. Hulvat MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jacqueline S. Jeruss MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jacqueline S. Jeruss MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hulvat, M.C., Jeruss, J.S. Maintaining Fertility in Young Women with Breast Cancer. Curr. Treat. Options in Oncol. 10, 308–317 (2009). https://doi.org/10.1007/s11864-010-0116-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11864-010-0116-2

Keywords

Search

Navigation